Theravance Biopharma TBPH
TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Other financing activities (2014 - 2026)

Updated

Theravance Biopharma (TBPH) reported Other financing activities of $2.1 million for Q2 2026, up 318.3% from $503,000 a year earlier but down 63.8% from the prior quarter.

Analysis

Theravance Biopharma (TBPH) Other financing activities (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Theravance Biopharma's Other financing activities came in at $10.58 million, up 359.6% year-over-year; for FY2025, it came in at $4.03 million, up 51.7% from FY2024.

  • Other financing activities has a five-year compound annual growth rate of -16.2% (FY2020 to FY2025).
  • By year, Other financing activities came in at $2.66 million in FY2024 (+6.4%), $2.5 million in FY2023 (-27.5%), $3.45 million in FY2022 (-61.9%) and $9.06 million in FY2021 (-7.1%).
  • Five-year quarterly Other financing activities spans a low of $347,000 in Q2 2022 and a high of $5.82 million in Q1 2026.
  • Year over year, Other financing activities has now increased in each of the last five quarters, with growth averaging 148.3% over the last eight quarters.
  • The high point for year-over-year Other financing activities in five years was Q1 2026 (growth of 565.7%); the low point was Q1 2022 (a decline of 74.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $5.82 million (Q1 2026), $1.98 million (Q4 2025) and $678,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Theravance Biopharma 883.70 Mn -543.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.10 Mn
Mar 31, 2026 -5.82 Mn
Dec 31, 2025 -1.98 Mn
Sep 30, 2025 -678,000.00
Jun 30, 2025 -503,000.00
Mar 31, 2025 -874,000.00
Dec 31, 2024 -528,000.00
Sep 30, 2024 -397,000.00
Jun 30, 2024 -464,000.00
Mar 31, 2024 -1.27 Mn
Dec 31, 2023 -518,000.00
Sep 30, 2023 -512,000.00
Jun 30, 2023 -583,000.00
Mar 31, 2023 -887,000.00
Dec 31, 2022 -1.99 Mn
Sep 30, 2022 -662,000.00
Jun 30, 2022 -347,000.00
Mar 31, 2022 -1.45 Mn
Dec 31, 2021 -455,000.00
Sep 30, 2021 -2.29 Mn
API Access

Theravance Biopharma Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=TBPH&period=max&api_key=YOUR_API_KEY